Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2024-11-03 20:16:59]
5 Years H Index
20
Impact Factor (IF)
0.1
5 Years IF
0.14
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1997 0 0.25 0 0 10 10 17 1 0 0 0 0 0.11
1998 0 0.28 0 0 12 22 8 1 10 10 0 0 0.13
2000 0 0.36 0 0 9 31 15 6 12 22 0 0 0.16
2001 0 0.39 0.09 0.1 3 34 4 3 9 9 31 3 2 66.7 0 0.17
2003 0 0.44 0.1 0.08 5 39 13 4 16 3 24 2 1 25 0 0.22
2004 0.2 0.5 0.05 0.06 1 40 3 2 18 5 1 17 1 0 0 0.22
2005 0 0.51 0.02 0 7 47 14 1 19 6 18 0 0 0.24
2006 0 0.51 0.16 0.06 62 109 125 17 36 8 16 1 15 88.2 13 0.21 0.23
2007 0.09 0.46 0.08 0.09 38 147 92 12 48 69 6 75 7 5 41.7 2 0.05 0.2
2008 0.07 0.49 0.07 0.08 22 169 265 11 59 100 7 113 9 4 36.4 0 0.23
2009 0.18 0.48 0.1 0.12 28 197 80 20 79 60 11 130 16 8 40 1 0.04 0.24
2010 0.4 0.49 0.2 0.25 33 230 77 46 125 50 20 157 39 11 23.9 0 0.21
2011 0.13 0.52 0.18 0.16 32 262 120 46 171 61 8 183 30 16 34.8 5 0.16 0.24
2012 0.42 0.52 0.36 0.39 93 355 183 127 298 65 27 153 59 64 50.4 26 0.28 0.22
2013 0.3 0.56 0.27 0.3 96 451 435 120 418 125 37 208 63 37 30.8 27 0.28 0.24
2014 0.19 0.55 0.19 0.18 110 561 363 108 526 189 35 282 52 29 26.9 18 0.16 0.23
2015 0.31 0.55 0.28 0.27 105 666 350 184 710 206 63 364 99 31 16.8 16 0.15 0.23
2016 0.26 0.53 0.24 0.25 133 799 271 192 902 215 56 436 111 36 18.8 12 0.09 0.21
2017 0.27 0.54 0.27 0.25 116 915 275 244 1147 238 65 537 135 60 24.6 28 0.24 0.22
2018 0.26 0.55 0.28 0.3 128 1043 172 291 1438 249 64 560 167 40 13.7 11 0.09 0.24
2019 0.28 0.57 0.31 0.26 132 1175 202 361 1799 244 68 592 155 60 16.6 33 0.25 0.23
2020 0.22 0.68 0.32 0.28 118 1293 81 415 2214 260 58 614 172 34 8.2 14 0.12 0.32
2021 0.22 0.81 0.29 0.22 114 1407 61 404 2618 250 55 627 137 38 9.4 18 0.16 0.3
2022 0.2 0.86 0.26 0.23 120 1527 33 400 3018 232 47 608 140 25 6.3 22 0.18 0.26
2023 0.1 0.92 0.18 0.14 86 1613 15 285 3303 234 24 612 88 8 2.8 3 0.03 0.27
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

242
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

200
32014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

88
42019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

75
52017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

66
62016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

48
72015The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689.

Full description at Econpapers || Download paper

44
82015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

35
92013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

35
102014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

34
11Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

33
122016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

32
132014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

30
142015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Meyerhoefer, Chad ; Cawley, John ; Biener, Adam ; Hammer, Mette ; Wintfeld, Neil . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

27
152012Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

26
162009Cost Effectiveness in Low- and Middle-Income Countries. (2009). Walker, Damian ; Goodman, Catherine ; Mills, Anne ; Shillcutt, Samuel . In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917.

Full description at Econpapers || Download paper

25
172014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

24
182015The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011.

Full description at Econpapers || Download paper

23
192017The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

23
202017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

20
212015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

20
222014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

19
232014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David ; Lanitis, Tereza . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

19
242015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

19
252014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

18
262018German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

18
272018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

17
282018A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5.

Full description at Econpapers || Download paper

17
292015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

17
302011Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619.

Full description at Econpapers || Download paper

16
312018Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z.

Full description at Econpapers || Download paper

16
322018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

15
332015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Crausaz, Steffan ; Clement, Fiona ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

15
342010Using Conjoint Analysis and Choice Experiments to Estimate QALY Values. (2010). Flynn, Terry. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:9:p:711-722.

Full description at Econpapers || Download paper

14
352016Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Kim, Jane J ; Verguet, Stephane ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z.

Full description at Econpapers || Download paper

14
362012Losing Sight of the Wood for the Trees. (2012). Peasgood, Tessa ; Dolan, Paul ; Lee, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1035-1049.

Full description at Econpapers || Download paper

14
372013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

14
382012Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747.

Full description at Econpapers || Download paper

14
392014Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375.

Full description at Econpapers || Download paper

14
40Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Muszbek, Noemi ; Ishak, K. ; Benedict, Agnes. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

13
41The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Liu, Gordon ; Xu, Fei. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292.

Full description at Econpapers || Download paper

13
422018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4.

Full description at Econpapers || Download paper

13
432019Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1.

Full description at Econpapers || Download paper

13
442016From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y.

Full description at Econpapers || Download paper

12
452006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin ; Liu, Chien-Hsiang ; Lee, Yue-Chune. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

12
462021The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Simes, Mark ; Sisitsky, Tammy ; Fournier, Andree-Anne ; Greenberg, Paul E ; Kessler, Ronald C ; Koenigsberg, Sarah H ; Berman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4.

Full description at Econpapers || Download paper

12
472017Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Fenwick, Elisabeth ; Koffijberg, Hendrik ; Ijzerman, Maarten J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1.

Full description at Econpapers || Download paper

12
482007Rates and Probabilities in Economic Modelling. (2007). Fleurence, Rachael ; Hollenbeak, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:3-6.

Full description at Econpapers || Download paper

12
492012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

12
502006Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework. (2006). McIntosh, Emma. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:855-868.

Full description at Econpapers || Download paper

12
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

38
22019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

38
32014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

25
42016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

25
52015The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689.

Full description at Econpapers || Download paper

23
62013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

21
72017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

20
82016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

14
92013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

13
102018A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5.

Full description at Econpapers || Download paper

12
112015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

11
122021The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Simes, Mark ; Sisitsky, Tammy ; Fournier, Andree-Anne ; Greenberg, Paul E ; Kessler, Ronald C ; Koenigsberg, Sarah H ; Berman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4.

Full description at Econpapers || Download paper

9
132018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

9
142019Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1.

Full description at Econpapers || Download paper

8
152018German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

8
162017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

8
172020Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Rowen, Donna ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7.

Full description at Econpapers || Download paper

7
182018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4.

Full description at Econpapers || Download paper

7
192014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

6
202017The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

6
212014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

6
222017Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Fenwick, Elisabeth ; Koffijberg, Hendrik ; Ijzerman, Maarten J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1.

Full description at Econpapers || Download paper

6
232018Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z.

Full description at Econpapers || Download paper

6
242019Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature. (2019). Prosser, Lisa A ; James, Lyndon P ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7.

Full description at Econpapers || Download paper

6
252022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022). Staniszewska, Sophie ; Bekker-Grob, Esther ; Pwu, Raoh-Fang ; Augustovski, Federico ; Petrou, Stavros ; Drummond, Michael ; Mullins, Daniel C ; Husereau, Don ; Mauskopf, Josephine ; Loder, Elizabeth ; Greenberg, Dan ; Chaiyakunapruk, Nathorn ; Caulley, Lisa ; Carswell, Chris ; Briggs, Andrew H. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:6:d:10.1007_s40273-021-01112-8.

Full description at Econpapers || Download Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2.

Full description at Econpapers || Download paper

5
272018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

5
282020Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Leidl, Reiner ; Gerdtham, Ulf-G. ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert ; Ulf-G. Gerdtham, . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7.

Full description at Econpapers || Download paper

5
292014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

5
302019Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe. (2019). Niewada, Maciej ; Graczyk, Katarzyna ; Jakubczyk, Micha ; Golicki, Dominik. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:9:d:10.1007_s40273-019-00811-7.

Full description at Econpapers || Download paper

5
312019The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments. (2019). Rodriguez-Ibeas, Roberto ; Lorente, Reyes ; Juarez-Castello, Carmelo ; Antonanzas, Fernando. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:12:d:10.1007_s40273-019-00838-w.

Full description at Econpapers || Download paper

5
322022Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic. (2022). Brouwer, Werner ; Kanters, Tim A ; Sajjad, Ayesha ; Exel, Job ; Roijen, Leona Hakkaart-Van. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01078-7.

Full description at Econpapers || Download paper

5
332022A Value Set for the EQ-5D-Y-3L in the Netherlands. (2022). Finch, Aureliano Paolo ; Stalmeier, Peep ; Lipman, Stefan ; Essers, Brigitte ; Sajjad, Ayesha ; Roudijk, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01192-0.

Full description at Econpapers || Download paper

5
342020Talkin’ About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices. (2020). Mestre-Ferrandiz, Jorge ; Shaw, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00877-3.

Full description at Econpapers || Download paper

4
352011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

4
362016Are Efficient Designs Used in Discrete Choice Experiments Too Difficult for Some Respondents? A Case Study Eliciting Preferences for End-of-Life Care. (2016). Flynn, Terry N ; Finkelstein, Eric A ; Malhotra, Chetna ; Bilger, Marcel. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:3:d:10.1007_s40273-015-0338-z.

Full description at Econpapers || Download paper

4
372015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

4
382006Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Wille, Nora ; Bullinger, Monika ; Erhart, Michael ; Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220.

Full description at Econpapers || Download paper

4
392016Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Kim, Jane J ; Verguet, Stephane ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z.

Full description at Econpapers || Download paper

4
402020A French Value Set for the EQ-5D-5L. (2020). Oppe, Mark ; Ramos, Juan Manuel ; Ludwig, Kristina ; Andrade, Luiz Flavio ; Pouvourville, Gerard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00876-4.

Full description at Econpapers || Download paper

4
412019Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges. (2019). Sraer, David ; Greenberg, Paul ; Thesmar, David ; Veliche, Razvan ; Dadson, Nick ; Pinheiro, Lisa. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:6:d:10.1007_s40273-019-00777-6.

Full description at Econpapers || Download paper

4
422021What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study. (2021). Kilian, Carolin ; Carr, Sinclair ; Hassan, Syed Ahmed ; Manthey, Jakob ; Rehm, Jurgen ; Kuitunen-Paul, Soren. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:7:d:10.1007_s40273-021-01031-8.

Full description at Econpapers || Download paper

4
432019Economic Spillover Effects of Intensive Unpaid Caregiving. (2019). Van Houtven, Courtney ; Tanielian, Terri ; Jacobs, Josephine C ; Ramchand, Rajeev. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00784-7.

Full description at Econpapers || Download paper

4
442021The Challenges of Measuring Informal Care Time: A Review of the Literature. (2021). Sutton, Matt ; Grande, Gunn ; Lau, Yiu-Shing ; Urwin, Sean. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01053-2.

Full description at Econpapers || Download paper

4
452011Cost-of-Illness Studies. (2011). Moss, John ; Larg, Allison . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:8:p:653-671.

Full description at Econpapers || Download paper

4
462023Modelling the Cost-Effectiveness of Diagnostic Tests. (2023). Snowsill, Tristan. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:4:d:10.1007_s40273-023-01241-2.

Full description at Econpapers || Download paper

4
472018Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review. (2018). , John ; John , ; Thayer, Winter Maxwell ; Zhou, MO. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0575-4.

Full description at Econpapers || Download paper

4
482020Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. (2020). Federici, Carlo ; Dams, Florian ; Ciani, Oriana ; Grigore, Bogdan ; Taylor, Rod S ; Zemplenyi, Antal ; Shatrov, Kosta ; Rabbe, Stefan ; Mollenkamp, Meilin ; Groot, Saskia. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00935-1.

Full description at Econpapers || Download paper

4
492015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

4
502012Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747.

Full description at Econpapers || Download paper

4
Citing documents used to compute impact factor: 24
YearTitle
2023
2023Informal caregiving and the allocation of time: implications for opportunity costs and measurement. (2023). Sutton, Matthew ; Grande, Gunn ; Lau, Yiu-Shing ; Urwin, Sean. In: Social Science & Medicine. RePEc:eee:socmed:v:334:y:2023:i:c:s027795362300521x.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Public preferences in healthcare resource allocation: A discrete choice experiment in South Korea. (2023). Lee, Boram ; Lim, Min Kyoung ; Bae, Eun-Young ; Hong, Jihyung. In: Health Policy. RePEc:eee:hepoli:v:138:y:2023:i:c:s0168851023002178.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Productivity and quality-adjusted life years: QALYs, PALYs and beyond. (2023). Moreno-Ternero, Juan ; Hansen, Kristian S ; Osterdal, Lars P. In: Working Papers. RePEc:hhs:cbsnow:2023_011.

Full description at Econpapers || Download paper

2023Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology. (2023). Attema, Arthur ; Shah, Koonal K ; Zhang, Liying ; Lipman, Stefan A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01466-6.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective co. (2023). Sapra, Sandhya ; Willson, Jenny ; Sansbury, Leah ; Gutierrez, Benjamin ; Gorsh, Boris ; Ferrante, Shannon ; Sopwith, Will ; de Nascimento, Julie ; Colin, Xavier ; Wang, Feng ; Bessou, Antoine ; Paka, Prani. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01463-9.

Full description at Econpapers || Download Marijuana Legalization and Mental Health. (2023). Romiti, Agnese ; Norris, Jonathan ; Lenhart, Otto ; Borbely, Daniel. In: Working Papers. RePEc:str:wpaper:2302.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2? Metastatic Breast Cancer in Postmenopausal Women in the USA. (2023). Trivedi, Meghana V ; Deshmukh, Ashish A ; Damgacioglu, Haluk ; Masurkar, Prajakta P. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01245-y.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Excess costs of multiple sclerosis: a register-based study in Sweden. (2023). Tinghog, Petter ; Murley, Chantelle ; Friberg, Emilie ; Karampampa, Korinna ; Hillert, Jan ; Alexanderson, Kristina ; Machado, Alejandra ; Teni, Fitsum Sebsibe. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01547-6.

Full description at Econpapers || Download paper

2023Guidance on the use of complex systems models for economic evaluations of public health interventions. (2023). Lomax, Nik ; Alava, Monica Hernandez ; Paisley, Suzy ; Hayes, Kate ; Cookson, Richard ; Strong, Mark ; Meier, Petra ; Brennan, Alan ; Kadirkamanathan, Visakan ; Dodd, Peter J ; Ennis, Kate ; Walsh, Cathal ; Boyd, Jennifer ; Robinson, Stewart ; Squires, Hazel ; Vale, Luke ; Smith, Robert ; Purshouse, Robin ; Breeze, Penny R ; Silverman, Eric ; Bayley, Thomas ; Gilbert, Nigel ; Siebert, Uwe ; Lawson, Kenny ; Oflaherty, Martin ; Scarborough, Peter ; Occhipinti, Joan ; de Vocht, Frank ; Sassi, Franco ; Shahab, Lion ; Kee, Frank ; Karapici, Amanda ; Briggs, Andrew ; Shiell, Alan ; Jackson, Christopher H. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:7:p:1603-1625.

2023Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands. (2023). Husbands, Samantha ; Hiligsmann, Mickael ; Morton, Rachael L ; Mitchell, Paul Mark ; Coast, Joanna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:4:d:10.1007_s10198-022-01498-y.

Full description at Econpapers || Download paper

2023
2023Trade Union Members’ Experiences and Attitudes towards Working from Home during the Pandemic. (2023). Garzia, Christine ; Debono, Manwel. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:3:p:1953-:d:1041653.

Full description at Econpapers || Download paper

2023A koronavírus-járvány a közgazdasági szakirodalomban. Egy új határterület tudománymetriai elemzése. (2023). Nagy, Andrea Magda ; Konka, Boglarka ; Torok, Adam. In: Közgazdasági Szemle (Economic Review - monthly of the Hungarian Academy of Sciences). RePEc:ksa:szemle:2111.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review. (2023). Gomes, Manuel ; Li, Keyi ; Ledger, Jean ; Aspinal, Fiona ; Morris, Tiyi. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:2:d:10.1007_s41669-022-00377-9.

Full description at Econpapers || Download paper

2023Including Young Children in the Development and Testing of Patient Reported Outcome (PRO) Instruments: A Scoping Review of Children’s Involvement and Qualitative Methods. (2023). Carlton, Jill ; Gale, Victoria. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:5:d:10.1007_s40271-023-00637-8.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2023

YearCiting document
2023Values in Modelling: Video Series Development and Evaluation Survey. (2023). Murphy, David ; Adibi, Amin ; McLean, Alison ; Werker, Greg ; Easterbrook, Adam ; Harvard, Stephanie. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:5:d:10.1007_s40258-023-00820-w.

Full description at Econpapers || Download paper

2023Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. (2023). Reginster, Jean-Yves ; Caminis, John ; Wang, Yamei ; Mathew, Jake ; Pearman, Leny ; Singer, Andrea J ; Silverman, Stuart S ; Hiligsmann, Mickael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:7:d:10.1007_s40273-023-01270-x.

Full description at Econpapers || Download paper

Recent citations received in 2022

YearCiting document
2022Where do measures of health, social care and wellbeing fit within a wider measurement framework? Implications for the measurement of quality of life and the identification of bolt-ons. (2022). Mulhern, Brendan ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622006761.

Full description at Econpapers || Download paper

2022The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”. (2022). Wang, Xiaofeng ; Kraan, Carla W ; Houwing, Natalie ; Piena, Marjanne A ; Bennison, Craig ; Waters, Heidi. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01213-y.

Full description at Econpapers || Download paper

2022An EQ-5D-Y-3L Value Set for Belgium. (2022). Ramos-Goi, Juan M ; Tollenaar, Nafthali H ; Roudijk, Bram ; Dewilde, Sarah. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01187-x.

Full description at Econpapers || Download paper

2022Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2.

Full description at Econpapers || Download paper

2022Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. (2022). Rivero-Arias, Oliver ; Shah, Koonal K ; Norman, Richard ; Kreimeier, Simone ; Devlin, Nancy J ; Mott, David J. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01214-x.

Full description at Econpapers || Download paper

2022Estimating an EQ-5D-Y-3L Value Set for China. (2022). Jing, Mingxia ; Li, Shunping ; Yu, Xiao ; Feng, DA ; Fang, YU ; Wu, Jing ; Wang, Pei ; Luo, Nan ; Jiang, Jie ; Huang, Weidong ; Yang, Zhihao ; Zheng, Bin. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01216-9.

Full description at Econpapers || Download paper

2022Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Gu, Ning Yan ; Pickard, Simon A ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x.

Full description at Econpapers || Download paper

2022EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions. (2022). Stolk, Elly ; Viney, Rosalie ; Roudijk, Bram ; Devlin, Nancy. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01226-7.

Full description at Econpapers || Download paper

2022Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China. (2022). Chen, Yixuan ; Li, Huangqianyu ; Wei, Yuxuan ; Zhang, Yichen ; Guan, Xiaodong ; Shi, Luwen ; Guo, Yiran. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01161-7.

Full description at Econpapers || Download paper

Recent citations received in 2021

YearCiting document
2021Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling. (2021). Adibi, Amin ; Symons, John ; Winsberg, Eric ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:286:y:2021:i:c:s0277953621006559.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021The Health and Productivity Burden of Depression in South Korea. (2021). Ademi, Zanfina ; Liew, Danny ; Rhee, Yongjoo ; Zomer, Ella. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00649-1.

Full description at Econpapers || Download paper

2021EQ-5D-Y Population Norms for Japanese Children and Adolescents. (2021). Fukuda, Takashi ; Shiroiwa, Takeru. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01063-0.

Full description at Econpapers || Download paper

2021Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting. (2021). Postma, Maarten J ; Villar, Fernando Antoanzas ; Garcia, Paula Rojas ; Pol, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01104-8.

Full description at Econpapers || Download paper

2021Authors’ Reply to Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”. (2021). Veenstra, David L ; Carlson, Josh J ; Neuberger, Edward E. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-021-01006-9.

Full description at Econpapers || Download paper

2021Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States. (2021). Bright, Jennifer L ; Linthicum, Mark T ; Malik, Erica Defur ; Xie, Richard Z. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01036-3.

Full description at Econpapers || Download paper

2021The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. (2021). Nellesen, Dave ; Greenberg, Paul ; Proudman, David. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01040-7.

Full description at Econpapers || Download paper

Recent citations received in 2020

YearCiting document
2020Health Economics Tools and Precision Medicine: Opportunities and Challenges. (2020). Scott, Ramsey ; Josh, Peterson ; Peter, Neumann ; Jeanne, Mandelblatt ; Anirban, Basu ; David, Veenstra. In: Forum for Health Economics & Policy. RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1.

Full description at Econpapers || Download paper

2020
2020Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia. (2020). Byford, Sarah ; Aceituno, David ; Achilla, Evanthia ; Robinson, Stewart ; Tappenden, Paul ; Jin, Huajie. In: PLOS ONE. RePEc:plo:pone00:0234996.

Full description at Econpapers || Download paper

2020Stakeholder-Engaged Derivation of Patient-Informed Value Elements. (2020). Dosreis, Susan ; Slejko, Julia F ; Zhang, Chengchen ; Hong, Yoon Duk ; Kennedy, Annie ; Caicedo, Juan ; Butler, Beverly. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:5:d:10.1007_s40271-020-00433-8.

Full description at Econpapers || Download paper

2020External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions. (2020). Johansen, Pierre ; Lamotte, Mark ; Lopes, Sandra ; Foos, Volker ; Olivieri, Anamaria-Vera ; McEwan, Phil. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00941-3.

Full description at Econpapers || Download paper

2020Reflections on NICE’s Uptake of New Methods: Past, Present, and the 2020 Review. (2020). Watson, Ian ; Boysen, Meindert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-020-00888-5.

Full description at Econpapers || Download paper

2020Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling. (2020). Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max ; Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9.

Full description at Econpapers || Download paper

2020Response to Comment on “Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”. (2020). Denniston, Alastair K ; Carrera, Vanesa Huertas ; Joore, Manuela A ; Petersohn, Svenja ; Kleijnen, Jos ; Riemsma, Rob ; Noake, Caro ; Worthy, Gill ; Witlox, Willem ; Armstrong, Nigel ; Raatz, Heike ; Chalker, Annette. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:6:d:10.1007_s40273-020-00900-y.

Full description at Econpapers || Download Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?. (2020). Prasad, Vinay ; Tran, Audrey A. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00920-8.

Full description at Econpapers || Download paper

2020What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?. (2020). McQueen, Brett R. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00924-4.

Full description at Econpapers || Download paper

2020Why it’s Time to Abandon the ICER. (2020). Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00915-5.

Full description at Econpapers || Download paper

2020Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?. (2020). Omahony, James F. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00931-5.

Full description at Econpapers || Download paper

2020Keeping Pace with Pharmaceutical Innovation: The Importance of the NICE Methods Review. (2020). Barrett, Victoria ; Catchpole, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00918-2.

Full description at Econpapers || Download paper

2020Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. (2020). Mattingly, T. Joseph ; Khokhar, Bilal ; Love, Bryan L. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00933-3.

Full description at Econpapers || Download paper